Long-template applications using NGS technologies to identify haplotypes and structural variations in complex genomes
Application of our propriety Target Reporter Construct (TRC) technology for:
(i) early detection and monitoring of circulating disease biomarkers
(ii) point-of care analysis of STDs in the clinic
HIV forensics
Nucleic acid chemistry
Sequencing technologies
Long template patents
Pending US 2017/0067097Issued EP No. 3 129 505
TRC patents
Issued U.S Patent No. US 11,299,769Pending US 2022/0307076Issued EP No. 3 464 628Pending EP No. 4 372 102